Cargando…
Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway
Cutaneous melanoma is the leading cause of death among skin cancers despite the availability of diverse treatments. FGD1 plays an important role in multiple cancers, but how it works in cutaneous melanoma has not been illustrated. Thus, this study was intended to investigate the roles of FGD1 and it...
Autores principales: | Niu, Zehao, Li, Yan, Xu, Yujian, Jiang, Weiqian, Tao, Ran, Chen, Youbai, Han, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810171/ https://www.ncbi.nlm.nih.gov/pubmed/34783295 http://dx.doi.org/10.1080/21655979.2021.2005877 |
Ejemplares similares
-
Leukemia-associated RhoGEF (LARG) is a novel RhoGEF in cytokinesis and required for the proper completion of abscission
por: Martz, Matthew K., et al.
Publicado: (2013) -
Rho GTPase–independent regulation of mitotic progression by the RhoGEF Net1
por: Menon, Sarita, et al.
Publicado: (2013) -
Tension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF
por: Scott, David W., et al.
Publicado: (2016) -
The RGS-RhoGEFs control the amplitude of YAP1 activation by serum
por: Lane, Brandon S., et al.
Publicado: (2021) -
Crystal structures of the PH domains from Lbc family of RhoGEFs bound to activated RhoA GTPase
por: Chen, Zhe, et al.
Publicado: (2018)